Fused heterocyclic amido compounds as anti-hepatitis C virus agents
Hiroshi Aoyama1, Kazuyuki Sugita, Masahiko Nakamura
1Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan. aoyama@iam.u-tokyo.ac.jp
Abstract:
We identified a fused heteroaromatic amido structure based on the phenanthridine skeleton as a superior scaffold for candidate drugs with potent anti-HCV activity. Among the compounds synthesized, a phenanthridine analogue with a 1,3-dioxolyl group (24) possessed the most potent anti-HCV activity (EC(50) value: 50 nM), with acceptable cytotoxicity. The structural development and structure-activity relationships of these compounds are described.
Related Concept Videos
Hepatitis
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction
Inhibitors Of Virion Release
Antifungal Agents


